ATE68700T1 - Nichttoxische ophthalmische zubereitungen und verfahren zu ihrer herstellung. - Google Patents

Nichttoxische ophthalmische zubereitungen und verfahren zu ihrer herstellung.

Info

Publication number
ATE68700T1
ATE68700T1 AT86304037T AT86304037T ATE68700T1 AT E68700 T1 ATE68700 T1 AT E68700T1 AT 86304037 T AT86304037 T AT 86304037T AT 86304037 T AT86304037 T AT 86304037T AT E68700 T1 ATE68700 T1 AT E68700T1
Authority
AT
Austria
Prior art keywords
manufacture
processes
ophthalmic preparations
preparation
optionally
Prior art date
Application number
AT86304037T
Other languages
English (en)
Inventor
Jeffrey P Gilbard
Original Assignee
Retina Found Eye Res Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24970192&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE68700(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Retina Found Eye Res Inst filed Critical Retina Found Eye Res Inst
Application granted granted Critical
Publication of ATE68700T1 publication Critical patent/ATE68700T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT86304037T 1985-05-29 1986-05-28 Nichttoxische ophthalmische zubereitungen und verfahren zu ihrer herstellung. ATE68700T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US73895385A 1985-05-29 1985-05-29
EP86304037A EP0205279B1 (de) 1985-05-29 1986-05-28 Nichttoxische ophthalmische Zubereitungen und Verfahren zu ihrer Herstellung

Publications (1)

Publication Number Publication Date
ATE68700T1 true ATE68700T1 (de) 1991-11-15

Family

ID=24970192

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86304037T ATE68700T1 (de) 1985-05-29 1986-05-28 Nichttoxische ophthalmische zubereitungen und verfahren zu ihrer herstellung.

Country Status (6)

Country Link
US (2) US4775531A (de)
EP (1) EP0205279B1 (de)
JP (1) JPH07108856B2 (de)
AT (1) ATE68700T1 (de)
CA (1) CA1263606A (de)
DE (1) DE3682117D1 (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0362277A4 (en) * 1987-06-01 1990-11-28 Allergan, Inc Preservative free ophthalmic ointments
US5221537A (en) * 1988-09-02 1993-06-22 Gerald Hecht Tissue irrigating solutions
US5460834A (en) * 1991-12-13 1995-10-24 Alcon Laboratories, Inc. Combinations of polymers for use in physiological tear compositions
EP0546728A3 (en) * 1991-12-13 1993-09-08 Alcon Laboratories Inc Physiological tear compositions and methods for their preparation
US5290572A (en) * 1992-08-06 1994-03-01 Deo Corporation Opthalmic composition for treating dry eye
US5830508A (en) * 1992-08-06 1998-11-03 Deo Corporation Composition for treating dry eye
CN1045383C (zh) * 1993-04-07 1999-10-06 王慧康 用于治疗老年性白内障的药物组合物
US5545617A (en) * 1993-11-12 1996-08-13 The Schepens Eye Research Institute, Inc. Therapeutic regulation of abnormal conjunctival goblet cell mucous secretion
CA2134376C (en) * 1993-12-20 2001-10-23 Haresh G. Bhagat Combinations of polymers for use in physiological tear compositions
IT1273011B (it) * 1994-07-25 1997-07-01 Trhecnopharma S A Preparato oftalmico per l'uso come lacrima artificiale
US5767105A (en) * 1995-05-03 1998-06-16 Peyman; Gholam A. Ocular solution
DE69730476T2 (de) * 1996-04-19 2005-11-17 Tsubota, Kazuo, Funabashi Albumin als aktiver Bestandteil zur Behandlung von Bindehaut- und Hornhautverletzungen und von trockenen Augen
JP3060133U (ja) * 1997-10-27 1999-07-30 株式会社大塚製薬工場 眼灌流・洗浄液バッグ包装体
US6455583B1 (en) * 1998-05-08 2002-09-24 The University Of Miami Method for treating meibomian gland disease
US6432934B1 (en) * 1998-08-06 2002-08-13 Advanced Vision Research Methods and compositions for topical treatment of eye surface inflammation and related dry eye disease
US6153582A (en) * 1998-11-05 2000-11-28 Bausch & Lomb Surgical, Inc. Defined serumfree medical solution for ophthalmology
US7524511B1 (en) * 2000-07-12 2009-04-28 Rogue Valley Natural Springs, Inc. Method and kit for moisturizing the surface of the eye
WO2003043548A1 (en) * 2001-11-20 2003-05-30 Visco Dye Aps Visco dye
US7897642B1 (en) * 2002-06-19 2011-03-01 Dr. Irvine Dubow Compositions and methods for dry eye syndrome
US8420699B1 (en) 2002-06-19 2013-04-16 Irvine L. Dubow Composition and methods of treatment using deionized and ozonated solution
AU2003270325A1 (en) * 2002-09-05 2004-03-29 Neurogesx, Inc. Compositions and kits for the removal of irritating compounds from bodily surfaces
US9297928B2 (en) 2004-11-22 2016-03-29 Johnson & Johnson Vision Care, Inc. Ophthalmic compositions comprising polyether substituted polymers
US8388995B1 (en) 2006-02-03 2013-03-05 Auburn University Controlled and extended delivery of hyaluronic acid and comfort molecules via a contact lens platform
US8349352B2 (en) * 2005-02-04 2013-01-08 Auburn University Therapeutic contact lenses with anti-fungal delivery
MX2007009417A (es) * 2005-02-04 2007-08-17 Univ Auburn Sistema de suministro de farmaco de contacto.
US9238003B2 (en) 2005-02-04 2016-01-19 Auburn University Extended or continuous wear silicone hydrogel contact lenses for the extended release of comfort molecules
EA013056B1 (ru) * 2005-04-01 2010-02-26 Ньюроджесэкс, Инк. Масла капсаициноидов и способы их получения и применения
EP1906949B1 (de) * 2005-07-01 2015-02-11 SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. Verwendung von l-carnitin oder von alkanoyl-l-carnitinen zur herstellung eines physiologischen ergänzungsmittels oder medikaments zur ophthalmischen anwendung in form von augentropfen
US20070207116A1 (en) * 2006-03-01 2007-09-06 Brown David C Antioxidant compositions for the eye
US20080138408A1 (en) * 2006-11-13 2008-06-12 Siddharth Venkatesh Drug delivery system and method
US8163358B2 (en) * 2009-02-18 2012-04-24 Synergeyes, Inc. Surface modification of contact lenses
JP4644305B1 (ja) * 2010-05-12 2011-03-02 喜美雄 川村 点眼薬及びその製造方法
WO2013046059A2 (en) * 2011-09-27 2013-04-04 Sykora Robert C Methods and compositions for tamarind-based ocular disease treatment in combination with trehalose
EP2999775A4 (de) * 2013-05-23 2016-06-08 Smm Ventures Llc Sklerallinsenslösung
US9259437B2 (en) 2013-05-23 2016-02-16 Smm Ventures, Llc Scleral lens solution
ES2909998T3 (es) * 2016-10-14 2022-05-11 I Com Medical Gmbh Método para establecer, restablecer y preservar la homeostasis de la superficie ocular

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2547653A (en) * 1948-03-10 1951-04-03 Bradford R Minnis Fluid for use in contact with the human eyeball
US3676553A (en) * 1969-12-15 1972-07-11 Cybersol Therapeutic composition
US3897550A (en) * 1971-06-01 1975-07-29 Cybersol Method for administering water soluble drugs, nutrients and other solutes to a mammal
US3821368A (en) * 1971-06-01 1974-06-28 Cybersal Inc Therapeutic composition
US3843782A (en) * 1971-07-26 1974-10-22 Flow Pharma Inc Eye solution and method of using same
US4371522A (en) * 1979-04-25 1983-02-01 Gilbard Jeffrey P Keratoconjunctivitis sicca therapy
US4443432A (en) * 1981-10-05 1984-04-17 Alcon Laboratories, Inc. Ophthmalic irrigating solution
US4550022A (en) * 1981-10-05 1985-10-29 Alcon Laboratories, Inc. Tissue irrigating solution
JPS59101421A (ja) * 1982-11-29 1984-06-12 Kaken Pharmaceut Co Ltd 眼科用潅流液

Also Published As

Publication number Publication date
EP0205279B1 (de) 1991-10-23
JPH07108856B2 (ja) 1995-11-22
US4775531A (en) 1988-10-04
JPS6226225A (ja) 1987-02-04
EP0205279A1 (de) 1986-12-17
US4911933A (en) 1990-03-27
CA1263606A (en) 1989-12-05
DE3682117D1 (de) 1991-11-28

Similar Documents

Publication Publication Date Title
ATE68700T1 (de) Nichttoxische ophthalmische zubereitungen und verfahren zu ihrer herstellung.
IL97538A0 (en) Liposomes containing an aminoglycoside salt and their preparation
AU687112B2 (en) Methods for increasing extracellular adenosine and for stabilization mast cells
GR3032958T3 (en) Ophthalmic preparation for use as artificial tear
ATE265856T1 (de) Augenlösung mit tetracyclin für behandlung von trockenen augen
EP0157476A3 (en) Improvements in or relating to ophthalmic lenses
ES8203224A1 (es) Procedimiento de preparacion de globulos rojos concentrados para almacenamiento.
NO179953C (no) Kvantitativ metode for bestemmelse av 1,4-dihydronikotinamid-adenin-dinukleotid i opplösning, samt engangs enzymelektrode
GB2187955B (en) Improvements in or relating to the treatment of sickle cell disease
DE3777611D1 (de) Lysozyme hydrochlorid und dikaliumglycyrrhizinat enthaltende loesung.
ATE95564T1 (de) Aeusseres membranprotein f von pseudomonas aeruginosa.
ATE10573T1 (de) Salzgemisch, verfahren zu seiner herstellung und verwendung.
CA2001552A1 (en) Cyclophosphamide - sodium bicarbonate lyophilizates
ATE33620T1 (de) Wasserloesliche zusammensetzungen zur herstellung analytischer loesungen.
PT81970B (pt) Processo para a preparacao de um reagente para a dosagem, por hemaglutinacao, de anticorpos contra as toxinas bacterianas
DE58903876D1 (de) Riboflavin-4'5'-cyclo-phosphorsaeureesterchlorid, dessen herstellung und verwendung zur herstellung von riboflavin-5'-phosphat (5'-fmn) bzw. dessen natriumsalz.
AU562517B2 (en) Biostimulating agent containing creatine
DK251284A (da) Substituerede 1,2,3-triazino(4',5'.4,5)thieno(2,3-b)-quinolin-4(3h)-oner eller syreadditionssalte deraf og deres fremstilling
JPS5664784A (en) Cultivating method of chlorella at high concentration
FR2594694B3 (fr) Association renfermant a titre de principes actifs, un agent mucolytique et l'acide adenosine triphosphorique ou un de ses sels
DE68905796D1 (de) Chromoglycinsaeure-natriumsalz enthaltende aerosolzubereitungen.
Chollet et al. Isolation of a Stable Enzyme multiplied by super (14) CO sub (2) multiplied by Mg super (2+) multiplied by Carboxyarabinitol Bisphosphate Complex With Ribulosebisphosphate Carboxylase From Chromatium vinosum.
ES8604885A2 (es) Mejoras en el objeto de la patente de invencion n 527.268 que se refiere a procedimiento de obtencion de nuevos derivados imidazolicos del acido 2-hidroxibenzoico
ES512751A0 (es) "procedimiento para la preparacion de un colirio antiseptico para afecciones oculares".
PL272875A3 (en) Method of obtaining pure sodium salt of 2-/2,6-dichloroanillin/-phenylacetic acid

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee